HomeMedical SpecialtiesCardiologyWorld’s first TAVI procedure on pregnant patient

World’s first TAVI procedure on pregnant patient

Published on

For just a moment, put yourself in Sarah Sayle’s shoes.

You’re a busy mom of two even busier girls, both under the age of two. Juggling the daily demands of an infant and a toddler, you learn there’s one more on the way. This time, a baby boy. Life’s about to get a whole lot busier.

Is your head already spinning? Few can relate, let alone imagine life with three little ones under three. Still, Sarah and her husband are prepared to take it all in stride.

Suddenly, a second wave of news strikes: Sarah, 29, who was born with a congenital heart defect, needs to have heart surgery. Her aortic valve has given out under the physical stress of pregnancy.

“I didn’t know what was going to happen,” said her husband. “She went for a doctor’s appointment in the morning, was supposed to be back by noon and instead was admitted to hospital.”

MORE: WHERE WILL THE NEXT GENERATION OF CEOS COME FROM?

Sarah needed to make a decision right away. She had three options: wait until her baby was born to have open-heart surgery, risking death for both her and/or her unborn child in the meantime; terminate the pregnancy and proceed with open-heart surgery; or undergo a specialized valve replacement while – something that had never been done before.

Sarah’s decision was clear. At sixteen weeks pregnant, she underwent a transcatheter aortic valve implantation () procedure, where a new valve is inserted into the heart via an incision made in the groin. For TAVI patients, the physical stress and recovery of the surgery is minimized – the best option for those who are too frail or in unique situations such as Sarah’s.

“Our main goal was to save Sarah’s life,” says Dr. Rich Whitlock, cardiac surgeon at Hamilton General Hospital.

Although Dr. Whitlock and his team were confident that TAVI was the best option for Sarah, it took careful planning and collaboration between both the cardiac and obstetrics teams to ensure a smooth journey for both mom and baby.

“Everyone was constantly checking in on me,” says Sarah. “My obstetrician even visited me in recovery at the General to make sure everything was okay.”

Sarah recovered well from her surgery. On Sept. 22, Sarah and her family welcomed a healthy baby boy, Peter, weighing 7lbs 12oz. He spent his first few days being closely monitored by staff and physicians in the neonatal intensive care unit at McMaster Children’s Hospital before heading home to meet his two big sisters.

MORE: MAKING PATIENTS OUR PARTNERS

“Sarah’s case is something you read about in a textbook,” says Dr. Michelle Morais, obstetrician at McMaster University Medical Centre who helped to deliver baby Peter. “You maybe see it once or twice in a career.”

Dr. Morais says other health care teams will read about and learn from Sarah’s case, a world first not only due to her pregnancy, but also her age – she’s the youngest TAVI patient to date. The learnings shared between the two teams are invaluable for future TAVI and other cases. Together, they’ve exemplified the epitome of collaboration and interdisciplinary care, and the positive outcomes for both Sarah and baby Peter are proof.

“It was perfect,” says Dr. Whitlock. “It was a textbook case.”

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

Canada's doctors are concerned that false health information and disconnected health systems are putting...

More like this

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

An individualized and equitable approach: Pregnancy care for people with disabilities

HN Summary • Sunnybrook’s Accessible Care Pregnancy Clinic provides individualized, fully accessible care for people...

First-in-Canada case of sustained HIV remission

HN Summary • A first-in-Canada case shows a patient achieving sustained HIV remission following a...

UHN researchers investigate new therapies as colon cancer rises among young patients

HN Summary • Colorectal cancer is rising among younger adults, prompting UHN researchers to investigate...